Parallax Volatility Advisers’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,600
Closed -$6.74M 1455
2025
Q4
$6.74M Buy
20,600
+600
+3% +$190K 0.01% 587
2025
Q3
$5.64M Sell
20,000
-22,500
-53% -$6.53M 0.01% 645
2025
Q2
$11.9M Sell
42,500
-41,800
-50% -$11.8M 0.03% 381
2025
Q1
$26.3M Buy
84,300
+5,300
+7% +$1.57M 0.07% 221
2024
Q4
$20.6M Buy
79,000
+78,900
+78,900% +$23.4M 0.04% 340
2024
Q3
$32.2K Sell
100
-2,400
-96% -$785K ﹤0.01% 1868
2024
Q2
$781K Sell
2,500
-107,600
-98% -$31.6M ﹤0.01% 1325
2024
Q1
$31.3M Buy
110,100
+62,600
+132% +$18.3M 0.07% 226
2023
Q4
$13.7M Sell
47,500
-16,400
-26% -$4.47M 0.03% 497
2023
Q3
$17.2M Sell
63,900
-24,200
-27% -$6.04M 0.04% 373
2023
Q2
$19.6M Sell
88,100
-17,200
-16% -$3.99M 0.04% 351
2023
Q1
$25.5M Sell
105,300
-44,500
-30% -$10.9M 0.05% 324
2022
Q4
$39.3M Sell
149,800
-275,200
-65% -$73.8M 0.06% 332
2022
Q3
$95.8M Sell
425,000
-141,800
-25% -$34.4M 0.15% 126
2022
Q2
$138M Buy
566,800
+165,100
+41% +$40.5M 0.13% 108
2022
Q1
$97.1M Buy
+401,700
New +$92.3M 0.05% 142
2020
Q4
Sell
-54,200
Closed -$13.8M 2288
2020
Q3
$13.8M Sell
54,200
-6,500
-11% -$1.61M 0.01% 854
2020
Q2
$14.3M Sell
60,700
-188,500
-76% -$43M 0.02% 627
2020
Q1
$50.5M Sell
249,200
-445,400
-64% -$97.3M 0.06% 208
2019
Q4
$167M Buy
694,600
+238,800
+52% +$52.6M 0.19% 74
2019
Q3
$88.2M Buy
455,800
+293,700
+181% +$56.4M 0.1% 117
2019
Q2
$29.9M Buy
162,100
+34,600
+27% +$6.2M 0.03% 262
2019
Q1
$24.2M Sell
127,500
-85,900
-40% -$16.4M 0.03% 276
2018
Q4
$41.5M Buy
213,400
+4,100
+2% +$800K 0.05% 217
2018
Q3
$43.4M Buy
209,300
+179,300
+598% +$35.3M 0.05% 159
2018
Q2
$5.54M Sell
30,000
-240,100
-89% -$42.5M 0.01% 589
2018
Q1
$46M Buy
+270,100
New +$49.6M 0.06% 146
2017
Q4
Sell
-5,000
Closed -$932K 3915
2017
Q3
$932K Sell
5,000
-67,200
-93% -$11.9M ﹤0.01% 1096
2017
Q2
$12.4M Sell
72,200
-630,700
-90% -$103M 0.02% 347
2017
Q1
$115M Buy
702,900
+680,300
+3,010% +$113M 0.24% 65
2016
Q4
$3.3M Sell
22,600
-8,300
-27% -$1.25M 0.01% 770
2016
Q3
$5.15M Buy
30,900
+5,900
+24% +$998K 0.01% 663
2016
Q2
$3.8M Buy
25,000
+24,800
+12,400% +$3.86M 0.01% 706
2016
Q1
$30K Sell
200
-68,800
-100% -$10.2M ﹤0.01% 2231
2015
Q4
$11.2M Buy
69,000
+28,800
+72% +$4.53M 0.02% 422
2015
Q3
$5.56M Sell
40,200
-47,300
-54% -$7.46M 0.01% 646
2015
Q2
$13.4M Sell
87,500
-119,400
-58% -$19.1M 0.03% 397
2015
Q1
$33.1M Sell
206,900
-46,000
-18% -$7.24M 0.08% 197
2014
Q4
$40.3M Sell
252,900
-398,300
-61% -$62.1M 0.12% 165
2014
Q3
$91.5M Buy
651,200
+506,200
+349% +$66.1M 0.29% 65
2014
Q2
$17.2M Sell
145,000
-63,000
-30% -$7.29M 0.07% 209
2014
Q1
$25.7M Sell
208,000
-15,800
-7% -$1.92M 0.15% 133
2013
Q4
$25.5M Sell
223,800
-241,800
-52% -$27.5M 0.12% 157
2013
Q3
$52.1M Buy
465,600
+113,900
+32% +$12.4M 0.27% 71
2013
Q2
$34.7M Buy
+351,700
New +$36.5M 0.16% 109

Other funds holding AMGN

Parallax Volatility Advisers's AMGN Position: Q1 2026 in Review

Parallax Volatility Advisers increased its Amgen (AMGN) stake by 239,400% in Q1 2026, buying an estimated $1.71M and bringing the position to 4,790 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #837.

Parallax Volatility Advisers first reported a position in AMGN in Q1 2014 and has held it in 33 quarters since. The position peaked at $37.1M in Q4 2019. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Parallax Volatility Advisers held 4,790 shares of Amgen worth $1.65M as of Q1 2026.
  • Parallax Volatility Advisers bought 4,788 Amgen shares in Q1 2026, an estimated $1.71M.
  • Amgen made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #837 holding.
  • Parallax Volatility Advisers first reported a position in Amgen in Q1 2014 and has held it in 33 quarters since.
  • Parallax Volatility Advisers's Amgen position peaked at $37.1M in Q4 2019.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.